What's happening
This bill prohibits any cost sharing, including deductibles and copays, for prescription insulin under New York insurance policies.
Why it matters
Eliminates all out-of-pocket costs for insulin. By removing deductibles, copays, coinsurance, and any other cost sharing, this bill ensures that insured individuals pay nothing at the pharmacy for prescription insulin, regardless of how much or what type they require.
Goes beyond previous caps. The bill replaces an older $100-per-30-day supply cap with a complete ban on any patient cost-sharing, meaning even those who previously paid less than $100 per month will now pay zero.
Could improve medication adherence and health outcomes. By eliminating financial barriers, the bill aims to make insulin consistently affordable, potentially reducing medical complications and hospitalizations for people with diabetes.
Impacts insurance premiums and plan designs. Since insurers must now cover the full cost of insulin, there may be implications for how insurance policies are priced or structured, possibly affecting premiums or the distribution of costs across all policyholders.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Patients with covered insulin prescriptions
The bill would eliminate deductibles, copayments, coinsurance and other cost sharing for covered prescription insulin, replacing the $100 cap per thirty-day supply.
Insurers offering policies subject to the amended provisions
They would have to remove insulin cost sharing from policies or contracts issued, renewed, modified, altered or amended on or after January 1, 2025.
State insurance superintendent
The bill would prohibit cost sharing for covered prescription insulin despite the provisions otherwise allowing deductibles and coinsurance deemed appropriate by the superintendent.
Headline styles
End Insulin Copays
Plain English, a few words. Used as the page title.
Sponsors
59 Co-sponsors
- Steven Raga
- Emily Gallagher
- Sarahana Shrestha
- Jessica Gonzalez-Rojas
- Juan Ardila
- George Alvarez
- Taylor Darling
- Jeffrion Aubry
- Jo Anne Simon
- William Colton
- Chris Burdick
- Zohran Mamdani
- Monique Chandler-Waterman
- Marcela Mitaynes
- Demond Meeks
- Phil Steck
- Anna Kelles
- Jake Ryan Blumencranz
- Joe DeStefano
- Latrice Walker
- Amanda Septimo
- Yudelka Tapia
- Fred Thiele
- Khaleel Anderson
- Chris Tague
- Scott H. Bendett
- Alicia Hyndman
- Inez E. Dickens
- Michael Durso
- Tony Simone
- Harvey Epstein
- Catalina Cruz
- Maritza Davila
- Vivian Cook
- MaryJane Shimsky
- Jen Lunsford
- Alex Bores
- Brian F. Curran
- Dana Levenberg
- Edward Flood
- Brian Maher
- Jonathan Jacobson
- Kenny Burgos
- Pamela J. Hunter
- Brian Cunningham
- Jenifer Rajkumar
- Robert C. Carroll
- Angelo Santabarbara
- Chantel Jackson
- Sarah Clark
- Karines Reyes
- Joe Angelino
- Matthew Slater
- Brian Manktelow
- Aileen Gunther
- Nader Sayegh
- John K. Mikulin
- Matthew Simpson
- John Zaccaro Jr.
History
- Print number 4141a
- Amend (t) and recommit to insurance
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Insulin Out-of-Pocket Costs
In Assembly Committee · Insurance · Sponsor Gustavo Rivera
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4141--A
2023-2024 Regular Sessions
IN ASSEMBLY
February 10, 2023
Introduced by M. of A. FORREST, RAGA, GALLAGHER, SHRESTHA, GONZALEZ-RO- JAS, ARDILA, ALVAREZ, DARLING, AUBRY, SIMON, COLTON, BURDICK, MAMDANI, CHANDLER-WATERMAN, MITAYNES, MEEKS, STECK, KELLES, BLUMENCRANZ, DeSTE- FANO, WALKER, SEPTIMO, TAPIA, TAYLOR, THIELE,… Show allHide
Introduced by M. of A. FORREST, RAGA, GALLAGHER, SHRESTHA, GONZALEZ-RO- JAS, ARDILA, ALVAREZ, DARLING, AUBRY, SIMON, COLTON, BURDICK, MAMDANI, CHANDLER-WATERMAN, MITAYNES, MEEKS, STECK, KELLES, BLUMENCRANZ, DeSTE- FANO, WALKER, SEPTIMO, TAPIA, TAYLOR, THIELE, ANDERSON, TAGUE, BENDETT, HYNDMAN, DICKENS, DURSO, SIMONE, EPSTEIN, CRUZ, DAVILA, COOK, SHIMSKY, LUNSFORD, BORES, CURRAN, LEVENBERG, FLOOD, MAHER, JACOBSON, BURGOS, HUNTER, CUNNINGHAM, RAJKUMAR, CARROLL, SANTABARBARA, JACKSON, CLARK, REYES -- read once and referred to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the insurance law, in relation to prohibiting cost sharing for insulin
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subparagraph (B) of paragraph 15-a of subsection (i) of section 3216 of the insurance law, as amended by section 1 of part DDD of chapter 56 of the laws of 2020, is amended to read as follows:
(B) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, [the total amount] that [a covered person is required to pay out of pocket for] covered prescription insulin drugs shall [be capped at an amount not to exceed one hundred dollars per thirty-day supply, regardless of the amount or type of insulin needed to fill such covered person's prescription and regardless of the insured's] not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement.
§ 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221 of the insurance law, as amended by section 2 of part DDD of chapter 56 of the laws of 2020, is amended to read as follows:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02649-03-4
(B) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, [the total amount] that [a covered person is required to pay out of pocket for] covered prescription insulin drugs shall [be capped at an amount not to exceed one hundred dollars per thirty-day supply, regardless of the amount or type of insulin needed to fill such covered person's prescription and regardless of the insured's] not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement.
§ 3. Paragraph 2 of subsection (u) of section 4303 of the insurance law, as amended by section 3 of part DDD of chapter 56 of the laws of 2020, is amended to read as follows:
(2) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, [the total amount] that [a covered person is required to pay out of pocket for] covered prescription insulin drugs shall [be capped at an amount not to exceed one hundred dollars per thirty-day supply, regardless of the amount or type of insulin needed to fill such covered person's prescription and regardless of the insured's] not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement.
§ 4. This act shall take effect January 1, 2025 and shall apply to any policy or contract issued, renewed, modified, altered, or amended on or after such date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.